Second opinions change the course of cancer care for many patients, and Ohio State experts are now using telehealth tech to increase access to these life-saving services.

Head-and-neck cancer surgeon Ricardo Carrau, MD, discusses the OSUCCC – James Online Second Opinon Program, which helps cancer patients make treatment decisions with clarity and confidence.

Follow The James Cancer-Free World Podcast:
· YouTube: https://go.osu.edu/C27H
· Spotify: https://go.osu.edu/C8pY
· Apple Podcasts: https://go.osu.edu/C2n6

Subscribe to The James on YouTube: https://www.youtube.com/@UCXGasnfbCpWYVW2RLTDPn4Q

Learn more about cancer care and research at The Ohio State University: 
Home: https://cancer.osu.edu
Blog: https://cancer.osu.edu/blog
News: https://cancer.osu.edu/news

Second opinions change the course of cancer care for many patients, and Ohio State experts are now using telehealth tech to increase access to these life-saving services. Head-and-neck cancer surgeon Ricardo Carrau, MD, discusses the OSUCCC – James Online Second Opinon Program, which helps cancer patients make treatment decisions with clarity and confidence. Follow The James Cancer-Free World Podcast: · YouTube: https://go.osu.edu/C27H · Spotify: https://go.osu.edu/C8pY · Apple Podcasts: https://go.osu.edu/C2n6 Subscribe to The James on YouTube: https://www.youtube.com/@UCXGasnfbCpWYVW2RLTDPn4Q Learn more about cancer care and research at The Ohio State University: Home: https://cancer.osu.edu Blog: https://cancer.osu.edu/blog News: https://cancer.osu.edu/news

Episode 196: Innovations in Cancer Second Opinions, with Dr. Riccardo Carrau

Join us on The James Cancer-Free World Podcast as we talk to the top scientists and doctors at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). They’ll discuss – in easy-to-understand language – all the cutting-edge cancer research going on at Ohio State and how this is improving patient care and ultimately saving lives.

About the OSUCCC – James:
The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Since 1976, the OSUCCC – James has been a National Cancer Institute-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet ® designation, the highest honor an organization can receive for quality patient care and professional nursing practice.

Science

Join us on The James Cancer-Free World Podcast as we talk to the top scientists and doctors at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). They’ll discuss – in easy-to-understand language – all the cutting-edge cancer research going on at Ohio State and how this is improving patient care and ultimately saving lives. About the OSUCCC – James: The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Since 1976, the OSUCCC – James has been a National Cancer Institute-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet ® designation, the highest honor an organization can receive for quality patient care and professional nursing practice.

Join us on The James Cancer-Free World Podcast as we talk to the top scientists and doctors at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). They’ll discuss – in easy-to-understand language – all the cutting-edge cancer research going on at Ohio State and how this is improving patient care and ultimately saving lives.

About the OSUCCC – James:
The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Since 1976, the OSUCCC – James has been a National Cancer Institute-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News &amp; World Report and has achieved Magnet ® designation, the highest honor an organization can receive for quality patient care and professional nursing practice.

Share Episode 196: Innovations in Cancer Second Opinions, with Dr. Riccardo Carrau

Sign up to save your podcasts

Episode 196: Innovations in Cancer Second Opinions, with Dr. Riccardo Carrau

Episode 196: Innovations in Cancer Second Opinions, with Dr. Riccardo Carrau

More shows like The James Cancer-Free World Podcast

Manufacturing Tomorrow

Voices of Excellence from Arts and Sciences

One Degree Greater

The Ohio State University Inspire

Enginuity

KXplores Emerging Research

Project Narrative

Executive Education Conversations

Convergence: Where disciplines, innovation and entrepreneurship collide

Columbus Backstage Pass

CareerEQ

Faculty Affairs Leadership Podcast

Regenerative Champions

Drugs on the Docket

The Leadership Initiative

Discovering Sarah Piatt - America’s Lost Great Writer

Shakespeare in the Postcolonies

Crash Cart Emergency Medicine

OSU MedNet21